title: Soluble CD21 (sCD21) forms biologically active complexes with CD23: sCD21 is present in normal plasma as a complex with trimeric CD23 and inhibits soluble CD23-induced IgE synthesis by B cells.
abstract: A soluble form of CD21 (sCD21) of 135 kDa is spontaneously released by human B and T lymphocytes upon shedding of the extracellular domain of the molecule. By Western blotting, we have now identified two forms of sCD21 of Mr 135 and 90 kDa in normal human serum. We further demonstrate that sCD21 circulates in a complexed form with cleavage fragments of C3 and CD23, two previously identified ligands of the membrane CD21 receptor. The CD23 molecule was in the form of a trimer in the soluble complex purified from plasma by affinity chromatography on anti-CD21 Sepharose. The serum sCD21 complex was also found to contain IgE. The presence of IgE and of CD21 in a soluble complex that contains trimeric CD23 as the only form of soluble CD23 (sCD23) is in agreement with a model in which two of the three lectin heads of CD23 bind to the Cepsilon3 domain of IgE, thus leaving one of the heads available for interaction with CD21. We further demonstrate that sCD21 inhibits sCD23-induced IgE synthesis by IL-4-stimulated B cells. The results indicate that sCD21 in plasma retains the ligand-binding properties of the membrane CD21 receptor and exhibits immunoregulatory properties that may be relevant to allergic and inflammatory disorders.
authors.affiliation: INSERM U430, Hôpital Broussais, Paris, France.
authors.forename: V
authors.initials: V
authors.lastname: Frémeaux-Bacchi
authors.forename: E
authors.initials: E
authors.lastname: Fischer
authors.forename: S
authors.initials: S
authors.lastname: Lecoanet-Henchoz
authors.forename: J C
authors.initials: JC
authors.lastname: Mani
authors.forename: J Y
authors.initials: JY
authors.lastname: Bonnefoy
authors.forename: M D
authors.initials: MD
authors.lastname: Kazatchkine
mesh_terms: D001402:B-Lymphocytes / Q000187:drug effects / Q000378:metabolism; D003176:Complement C3 / Q000378:metabolism; D006801:Humans; D007073:Immunoglobulin E / Q000096:biosynthesis / Q000378:metabolism; D015847:Interleukin-4 / Q000494:pharmacology; D008024:Ligands; D010446:Peptide Fragments / Q000097:blood; D017434:Protein Structure, Tertiary; D017464:Receptors, Complement 3d / Q000097:blood / Q000378:metabolism* / Q000502:physiology; D017455:Receptors, IgE / Q000737:chemistry / Q000378:metabolism*; D012995:Solubility
chemical_list: D003176:Complement C3; D008024:Ligands; D010446:Peptide Fragments; D017464:Receptors, Complement 3d; D017455:Receptors, IgE; D015847:Interleukin-4; D007073:Immunoglobulin E